Global Automated Breast Ultrasound System (ABUS) Market Size | Projected Growth to US$ 1009.66 Mn by 2029, GE Healthcare and Siemens AG Among Key Players

Global Automated Breast Ultrasound Market Poised for $1 Billion Growth by 2029 Driven by Rising Demand for Early Cancer Detection

Maximize Market Research forecasts the Global Automated Breast Ultrasound System (ABUS) Market to reach US$1.01 billion by 2029, reflecting a significant increase in demand for more precise and accessible breast cancer screening tools. This press release highlights key findings from Maximize Market Research’s report on the ABUS Market.

Please provide the link you’d like me to access for the preview of the dynamic: 

Market Overview

Automated Breast Ultrasound Systems (ABUS) offer a non-invasive alternative to traditional mammograms, particularly beneficial for women with dense breast tissue. ABUS technology is gaining traction due to its accuracy in detecting breast abnormalities and its ability to provide real-time image guidance for biopsies.

Report Summary

Maximize Market Research’s comprehensive report offers a detailed analysis of the ABUS market, including growth factors, future trends, country-specific insights, market distribution channels, and a competitive landscape analysis of major industry players. The report dives deep into each market segment, identifying lucrative opportunities for businesses. Additionally, the regional analysis equips readers with a clear understanding of market developments across various geographic locations.


The ABUS market is segmented by Product Type (Prone, Supine) and End User (Hospitals, Diagnostic Centers, Ambulatory Care Centers). The report analyzes sales, revenue, and forecasts for each segment, empowering businesses with data-driven decision-making.

Market Players

The report examines prominent players in the ABUS market, including GE Healthcare, Siemens AG, Philips, Toshiba Corporation, and Hitachi. It assesses their market share, product portfolios, and future growth strategies.

Regional Insights

The report offers an in-depth analysis of the ABUS market across North America, Europe, Asia Pacific, South America, the Middle East, and Africa. North America is expected to remain the dominant market due to high healthcare spending and rising awareness about breast cancer screening. However, Asia Pacific is anticipated to witness the fastest growth due to increasing investments in healthcare infrastructure and a growing patient population.

Impact of COVID-19 on the Market

The COVID-19 pandemic caused temporary disruptions in the ABUS market due to delayed hospital procedures and supply chain issues. However, the market is expected to recover quickly as the focus on early cancer detection intensifies.

The Study Objectives of This Report Are

  • To classify the ABUS market structure by its various sub-segments.
  • To analyze the key factors influencing the growth of the market, including industry trends, opportunities, drivers, challenges, and market risks.
  • To provide insights into key global ABUS manufacturers, their sales volume, value, market share, competitive landscape, SWOT analysis, and future growth plans.
  • To project the market size for key regions and their respective countries.
  • To evaluate the economic and political market situation on a global, regional, and country level.

Maximize Market Research provides superior market research solutions to businesses worldwide. This report equips market participants in the ABUS Market with valuable data and insights to make informed decisions! 


Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India


Phone No.: +91 96071 95908, +91 9607365656


More Related Reports:

Global Hardware Security Modules Market

Cardiac Arrest Treatment Market

Global Aminoethylethanolamine Market